| MolName | (2R)-2-(N-[2-(benzotriazol-1-yl)acetyl]-2-fluoroanilino)-2-(4-morpholin-4-ylphenyl)-N-[[(2R)-oxolan-2-yl]methyl]acetamide |
| MolecularFormula | C31H33N6O4F |
| Smiles | O=C(Cn1nnc2c1cccc2)N([C@@H](C(NC[C@@H]1OCCC1)=O)c(cc1)ccc1N1CCOCC1)c(cccc1)c1F |
| InChI | InChI=1S/C31H33FN6O4/c32-25-7-1-3-9-27(25)38(29(39)21-37-28-10-4-2-8-26(28)34-35-37)30(31(40)33-20-24-6-5-17-42-24)22-11-13-23(14-12-22)36-15-18-41-19-16-36/h1-4,7-14,24,30H,5-6,15-21H2,(H,33,40)/t24-,30-/m1/s1 |
| InChIK | FKHATEUYNSPGAE-AYWVHJORSA-N |
| TotalMolweight | 572.639 |
| Molweight | 572.639 |
| MonoisotopicMass | 572.254732 |
| CLogP | 2.1502 |
| CLogS | -4.686 |
| H Acceptors | 10 |
| H Donors | 1 |
| TotalSurfaceArea | 429.85 |
| Relative PSA | 0.2174 |
| PolarSurfaceArea | 101.82 |
| Druglikeness | -2.0591 |
| Mutagenic | high |
| Tumorigenic | high |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | |
| Shape Index | 0.40476 |
| Fragments | 1 |
| Non HAtoms | 42 |
| NonCHAtoms | 11 |
| Electronegative Atoms | 11 |
| StereoCenters | 2 |
| Rotatable Bond | 9 |
| Rings Closures | 6 |
| Small Rings | 6 |
| Aromatic Rings | 4 |
| Aromatic Atoms | 21 |
| Sp3Atoms | 13 |
| Symmetricatoms | 4 |
| Amides | 2 |
| Amines | 1 |
| Aromatic Amines | 1 |
| Aromatic Nitrogens | 3 |
| StereoCon | this enantiomer |
Click to Load Molecule:
1 - (2R)-2-(N-[2-(benzotriazol-1-yl)acetyl]-2-fluoroanilino)-2-(4-morpholin-4-ylphenyl)-N-[[(2R)-oxolan-2-yl]methyl]acetamide | 2 - (2R)-2-(N-[2-(benzotriazol-1-yl)acetyl]-2-fluoroanilino)-2-(4-morpholin-4-ylphenyl)-N-[[(2R)-oxolan-2-yl]methyl]acetamide